More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
2025 Coalition for Common Sense in Government Procurement Winter Training Conference
Our experts look forward to exploring how we will use evidence, analytics, and disciplined implementation to improve program outcomes.
Abt Global Announces Partnership with Rhino.AI to Accelerate AI Modernization Across Federal Agencies
Abt Global announced a strategic partnership with Rhino.ai, a U.S. artificial intelligence company fast gaining acclaim for its automated modernization capabilities.
A State Playbook to Transform America’s Rural Health Workforce
An informative playbook to build, retain, and support the rural health workforce through GYO pipelines, pathways, residencies, telehealth, and team-based care.
CMS Crushing Fraud Chili Cookoff Showcase 2025
Abt Global is a finalist at the CMS Crushing Fraud Chili Cookoff Showcase 2025.